NA

Naveen Avtar Krishen Khosla

Director DIN 02617070
DIN 02617070 First appointment Oct 2008
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Naveen Avtar Krishen Khosla

Data last updated:

Naveen Avtar Krishen Khosla was a Director at Medipharmacy Bpo Private Limited (from 2009) and Director at Medipharmacy Healthcare Private Limited (from 2008).

DIN 02617070
First Appointment 03 Oct 2008
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medipharmacy Bpo Private Limited U72900GJ2008PTC054924
Director16 Nov 20092008Strike Off
Director03 Oct 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medipharmacy Bpo Private Limited
Medipharmacy Healthcare Private Limited
Premium access

Shareholding and investment profile for Naveen Avtar Krishen Khosla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naveen Avtar Krishen Khosla

Naveen Avtar Krishen Khosla was first appointed on 03 Oct 2008 as Director at Medipharmacy Healthcare Private Limited. The most recent appointment on record is 16 Nov 2009 at Medipharmacy Bpo Private Limited.

Naveen Avtar Krishen Khosla held 2 earlier board appointments: Medipharmacy Bpo Private Limited (Director, from 16 Nov 2009); Medipharmacy Healthcare Private Limited (Director, from 03 Oct 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available